The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis
Open accessAbstract
Expression of IL-22 is induced in several human inflammatory conditions, including inflammatory bowel disease (IBD). Expression of the IL-22 receptor is restricted to innate immune cells; however, the role of IL-22 in colitis has not yet been defined. We developed what we believe to be a novel microinjection-based local gene-delivery system that is capable of targeting the inflamed intestine. Using this approach, we demonstrated a therapeutic potency for IL-22-mediated activation of the innate immune pathway in a mouse model of Th2-mediated colitis that induces disease with characteristics similar to that of IBD ulcerative colitis (UC). IL-22 gene delivery enhanced STAT3 activation specifically within colonic epithelial cells and induced both STAT3-dependent expression of mucus-associated molecules and restitution of mucus-producing goblet cells. Importantly, IL-22 gene delivery led to rapid amelioration of local intestinal inflammation. The amelioration of disease by IL-22 was mediated by enhanced mucus production. In addition, local gene delivery was used to inhibit IL-22 activity through overexpression of IL-22-binding protein. Treatment with IL-22-binding protein suppressed goblet cell restitution during the recovery phase of a dextran sulfate sodium-induced model of acute colitis. These data demonstrate what we believe to be a novel function for IL-22 in the intestine and suggest the potency of a local IL-22 gene-delivery system for treating UC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Podolsky, D. K. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020831 · Cited by 3,159
A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene
Duerr, R. H., Taylor, K. D., Brant, S. R., Rioux, J. D., Silverberg, M. S., Daly, M. J., Steinhart, A. H., Abraham, C., Regueiro, M., Griffiths, A., et al. (2006) · Science · doi:10.1126/science.1135245 · Cited by 3,039
Liang, S. C., Tan, X.-Y., Luxenberg, D. P., Karim, R., Dunussi-Joannopoulos, K., Collins, M., & Fouser, L. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061308 · Cited by 2,330 · cited 3×
“In addition, IL-22 is preferentially produced by Th17 cells (4, 5), which have recently been shown to play a pathogenic role in CD-like experimental colitis (15, 16).”
BackgroundResultInterleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis
Zheng, Y., Danilenko, D. M., Valdez, P., Kasman, I., Eastham-Anderson, J., Wu, J., & Ouyang, W. (2007) · Nature · doi:10.1038/nature05505 · Cited by 1,862
Van der Sluis, M., De Koning, B. A. E., De Bruijn, A. C. J. M., Velcich, A., Meijerink, J. P. P., Van Goudoever, J. B., Büller, H. A., Dekker, J., Van Seuningen, I., Renes, I. B., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.04.020 · Cited by 1,684 · cited 2×
“Since Muc family members form a static external barrier along the epithelial cell surface (33, 34), we determined whether the rapid attenuation of chronic colitis induced by supplementation of IL-22 expression was mediated by the enhanced Muc expression observed.”
BackgroundIL-23 is essential for T cell–mediated colitis and promotes inflammation via IL-17 and IL-6
Yen, D., Cheung, J., Scheerens, H., Poulet, F., McClanahan, T., Mckenzie, B., Kleinschek, M. A., Owyang, A., Mattson, J., Blumenschein, W., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci21404 · Cited by 1,542
Treatment of Murine Colitis by Lactococcus lactis Secreting Interleukin-10
Steidler, L., Hans, W., Schotte, L., Neirynck, S., Obermeier, F., Falk, W., Fiers, W., & Remaut, E. (2000) · Science · doi:10.1126/science.289.5483.1352 · Cited by 1,513
IL-22 Increases the Innate Immunity of Tissues
Wolk, K., Kunz, S., Witte, E., Friedrich, M., Asadullah, K., & Sabat, R. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.007 · Cited by 1,359
The fundamental basis of inflammatory bowel disease
Strober, W., Fuss, I., & Mannon, P. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30587 · Cited by 1,319
Atreya, R., Mudter, J., Finotto, S., Müllberg, J., Jostock, T., Wirtz, S., Schütz, M., Bartsch, B., Holtmann, M., Becker, C., et al. (2000) · Nature Medicine · doi:10.1038/75068 · Cited by 1,293
Cited by
Items 101–121 of 121
Wolk, K., Warszawska, K., Hoeflich, C., Witte, E., Schneider-Burrus, S., Witte, K., Kunz, S., Buss, A., Roewert, H. J., Krause, M., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.0903907 · Cited by 254
Cytokines IL-17 and IL-22 in the host response to infection
Valeri, M., & Raffatellu, M. (2016) · Pathogens and Disease · doi:10.1093/femspd/ftw111 · Cited by 202
Bauché, D., Joyce-Shaikh, B., Jain, R., Grein, J., Ku, K. S., Blumenschein, W. M., Ganal-Vonarburg, S. C., Wilson, D. C., McClanahan, T. K., Malefyt, R. D. W., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.07.007 · Cited by 202
Kasembeli, M. M., Bharadwaj, U., Robinson, P., & Tweardy, D. J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082299 · Cited by 199
Optimized human intestinal organoid model reveals interleukin-22-dependency of paneth cell formation
He, G.-W., Lin, L., DeMartino, J., Zheng, X., Staliarova, N., Dayton, T., Begthel, H., van de Wetering, W. J., Bodewes, E., van Zon, J., et al. (2022) · Cell Stem Cell · doi:10.1016/j.stem.2022.08.002 · Cited by 178
“In an alternative role, IL-22 has been reported to act by inducing barrier protection against pathogens through goblet cell differentiation and mucin secretion (Layunta et al., 2021; Sugimoto et al., 2008; Turner et al., 2013), production of anti-microbial proteins (AMPs) (Gaudino et al.”
BackgroundEosinophils in Autoimmune Diseases
Diny, N. L., Rose, N. R., & Čiháková, D. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00484 · Cited by 172
Allen, J. M., Mailing, L. J., Cohrs, J., Salmonson, C., Fryer, J. D., Nehra, V., Hale, V. L., Kashyap, P., White, B. A., & Woods, J. A. (2018) · Gut Microbes · doi:10.1080/19490976.2017.1372077 · Cited by 152
Okubo, R., Koga, M., Katsumata, N., Odamaki, T., Matsuyama, S., Oka, M., Narita, H., Hashimoto, N., Kusumi, I., Xiao, J., et al. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.11.011 · Cited by 149
Saha, S., Jing, X., Park, S. Y., Wang, S., Li, X., Gupta, D., & Dziarski, R. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.07.005 · Cited by 137
The β-Glucan Receptor Dectin-1 Promotes Lung Immunopathology during Fungal Allergy via IL-22
Lilly, L. M., Gessner, M. A., Dunaway, C. W., Metz, A. E., Schwiebert, L., Weaver, C. T., Brown, G. D., & Steele, C. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201797 · Cited by 130
Immunoregulatory pathways involved in inflammatory bowel disease
Fonseca-Camarillo, G., & Yamamoto-Furusho, J. K. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000477 · Cited by 120
Jang, K. K., Heaney, T., London, M., Ding, Y., Putzel, G., Yeung, F., Ercelen, D., Chen, Y.-H., Axelrad, J., Gurunathan, S., et al. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.08.002 · Cited by 70
Helminthic therapy: improving mucosal barrier function
Wolff, M. J., Broadhurst, M. J., & Loke, P. (2012) · Trends in Parasitology · doi:10.1016/j.pt.2012.02.008 · Cited by 59
Helminth infection in populations undergoing epidemiological transition: a friend or foe?
Wiria, A. E., Djuardi, Y., Supali, T., Sartono, E., & Yazdanbakhsh, M. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-012-0358-0 · Cited by 54
A nonredundant role for T cell-derived interleukin 22 in antibacterial defense of colonic crypts
Zindl, C. L., Witte, S. J., Laufer, V. A., Gao, M., Yue, Z., Janowski, K. M., Cai, B., Frey, B. F., Silberger, D. J., Harbour, S. N., et al. (2022) · Immunity · doi:10.1016/j.immuni.2022.02.003 · Cited by 49
Dichotomous regulation of group 3 innate lymphoid cells by nongastric Helicobacter species
Bostick, J. W., Wang, Y., Shen, Z., Ge, Y., Brown, J., Chen, Z.-M. E., Mohamadzadeh, M., Fox, J. G., & Zhou, L. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1908128116 · Cited by 44
“To this end, we determined the action of Helicobacter in 2 models of colitis, dextran sodium sulfate (DSS)-induced colitis and Citrobacter rodentium infection, both of which depend on ILC3s for protective immunity (25, 34, 35).”
MethodThe role of osteopontin (OPN/SPP1) haplotypes in the susceptibility to Crohn’s disease
Glas, J., Seiderer, J., Bayrle, C., Wetzke, M., Fries, C., Tillack, C., Olszak, T., Beigel, F., Steib, C., Friedrich, M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029309 · Cited by 42
Dexamethasone suppresses interleukin-22 associated with bacterial infection in vitro and in vivo
Ziesché, E., Scheiermann, P., Bachmann, M., Sadik, C. D., Hofstetter, C., Zwissler, B., Pfeilschifter, J., & Mühl, H. (2009) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2009.03969.x · Cited by 40
Su, S.-B., Qin, S.-Y., Xian, X.-L., Huang, F.-F., Huang, Q.-L., ZhangDi, H.-J., & Jiang, H.-X. (2021) · Life Sciences · doi:10.1016/j.lfs.2020.118677 · Cited by 40
Drobny, A., Ngo, P. A., Neurath, M. F., Zunke, F., & López-Posadas, R. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.655123 · Cited by 24
Acoustic stress induces long term severe intestinal inflammation in the mouse
Miranda, S., & Roux, M. E. (2017) · Toxicology Letters · doi:10.1016/j.toxlet.2017.07.898 · Cited by 16
Metadata
- Authors
- Sugimoto, K., Ogawa, A., Mizoguchi, E., Shimomura, Y., Andoh, A., Bhan, A. K., Blumberg, R. S., Xavier, R. J., & Mizoguchi, A.
- Venue
- Journal of Clinical Investigation
- Published
- 2008-01-02
- Volume
- 118
- Issue
- 2
- Pages
- 534-44
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2007136776
- Cited by
- 1,023
- References
- 53
- FWCI
- 32.69
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.